OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Director exercised or converted 25K GMED derivative securities | OQRO

Home
Insider trades
Globus Medical
Director exercised or converted 25K GMED derivative securities

Insider trades

Insider trade

Director exercised or converted 25K GMED derivative securities

Traded Nov 12, 2025 · Filed Nov 13, 2025

GMEGlobus MedicalGMED

25K
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Nov 12, 2025
Reporting period: Not applicable
Filed with the SEC: Nov 13, 2025

DirectorOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001193125-25-280500

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Nov 13, 2025, 10:12 PM UTC

Added to OQRO

Oct 6, 2026, 7:37 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

GLOBUS MEDICAL INC

Issuer CIK

1237831

Ticker

GMED

Reporting person

David D Davidar

Relationship

Director

Security

Stock Option (Right to Buy Class A Common Stock)

Table

Derivative (Table II)

Transaction date

Nov 12, 2025

Transaction code

Shares / units

25,000

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

Ownership form

Direct

Amendment

Footnotes from the filing

These options were granted on January 25, 2016 and are fully vested.

Around the same time

David C PaulExecutive Chairman

Filed 10mo ago

34KShares · @ $25.52

Traded Dec 8, 2025 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

David C PaulExecutive Chairman

Filed 10mo ago

34KDerivative units

Traded Dec 8, 2025 · filed 2 days later

Derivative exercise or conversion — not an open-market buy.

More Official record

Kyle KlineSenior Vice President, CFO

Filed 10mo ago

5,000Shares · @ $64.44

Traded Dec 1, 2025 · filed 3 days later

Derivative exercise or conversion — not an open-market buy.

More Official record